PROF

Profound Medical Corp.

Price

$5.79

return (12m)

33.29%

p/e

-6.42

p/bv

4.22

DIVIDEND YIELD

0.00%

PROF price

Profound Medical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PROF

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-14.11%

3 months

-15.79%

1 year

33.29%

2 years

-26.21%

5 years

-59.00%

10 years

-40.08%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PROF

Valuation

P/E

-6.42

Sector 1.09

Industry -1.78

P/BV

4.22

Sector 1.86

Industry 1.35

P/Revenue (PSR)

11.02

Sector 1.55

Industry 2.25

EV/EBITDA

-15.74

Sector -47.62

Industry -42.38

EV/EBIT

-15.54

Sector -27.52

Industry -45.58

P/EBITDA

-6.03

Sector -32.64

Industry -23.10

P/EBIT

-5.95

Sector -43.02

Industry -27.18

P/Total Assets

3.37

Sector 0.87

Industry 0.82

P/Net Current Assets

4.54

Sector -27.09

Industry -72.46

P/Working Capital

4.23

Sector -4.05

Industry -2.10

EPS

-0.90

Sector -0.70

Industry -1.11

BVPS

1.37

Sector 4.34

Industry 2.54

Efficiency

Gross Margin

71.79%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-440.23%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-445.67%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-100.00%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-100.00%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.04

Sector 0.13

Industry 0.06

Profitability

ROE

-65.74%

Sector -24.32%

Industry -33.33%

ROA

-52.49%

Sector -24.41%

Industry -45.72%

ROIC

-210.47%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.46

Sector 1.90

Industry 2.51

Net Debt / EBITDA

3.50

Sector -4.96

Industry -8.98

Net Debt / EBIT

3.46

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.77

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.00

Sector -0.74

Industry -0.56

Equity/Assets

0.80

Sector 0.46

Industry 0.52

Liabilities/Assets

0.20

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

22.64%

Sector -

Industry -

5Y Earnings CAGR

1.30%

Sector -

Industry -

Fundamentals PROF

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PROF Profound Medical Corp.	$5.79	45.79%	0.00%	-6.42	4.22	-65.74%	-100.00%
ISRG Intuitive Surgical Inc.	$392.49	-9.49%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$102.63	-21.99%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.33	1.59%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.52	-55.82%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.47	-27.00%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$227.07	-15.55%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$512.11	-20.09%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$308.78	198.60%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$276.81	-25.56%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.65	-8.23%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.32	-4.12%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$88.64	15.96%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$180.03	-1.10%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$88.26	17.37%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.59	14.02%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$27.54	-23.70%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$82.52	17.96%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PROF Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Profound Medical

Profound Medical Corp.

Average Investor10 user rating

4.0 (0 people)

United States

12 years

Founded: 2014

2016

Time since IPO - 10 years

109

Employees

Profound Medical Corp. (United States) is listed on the Nasdaq and has a market capitalization of $210.29 million, with shareholders equity totaling $49.81 million.

The company employs approximately 109 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Profound Medical Corp. reported $19.09 million in revenue, generating net income of $-32.75 million.

Key financial metrics include a P/E ratio of -6.42, a price-to-book (P/B) ratio of 4.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PROF.

Market cap

$210.29 million

Net worth

$49.81 million

$49,808,000.00

Assets

$62.39 million

$62,385,000.00

Total Shares Outstanding

36.35 million

36,350,000

Average Daily Trading Volume

$115.96 Thousand

$115,964.60

Sector

Health

Industry

Medical Supplies and Equipment

PROF

PROF revenue and profits

Financial Results PROF

DRAG THE FRAME TO SEE MORE DATA

PROF cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.45 21,79% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.31 --3,58% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.99 107,71% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$384.07 54,21% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.38 --7,54% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,142.35 52,87% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$429.56 7,48% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$139.78 15,92% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35